![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Tehran University of Medical Sciences |
---|---|
Information provided by: | Tehran University of Medical Sciences |
ClinicalTrials.gov Identifier: | NCT00893100 |
The purpose of this study is to evaluate the effectiveness of diltiazem ointment 2 percent in reducing pain after hemorrhoidectomy.
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: Diltiazem |
Phase IV |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Double Blind (Subject, Investigator), Uncontrolled, Parallel Assignment, Efficacy Study |
Official Title: | Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2% |
Enrollment: | 1 |
Study Start Date: | October 2007 |
Study Completion Date: | December 2008 |
Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Diltiazem: Experimental |
Drug: Diltiazem
2%,3 times daily
|
Pain after hemorrhoidectomy remains a major postsurgical complication.Therefore pain management in patients is an important goal.Many studies have focused on surgical techniques,preoperative and postoperative regimes.We assessed a randomised double blind placebo-controlled trial to evaluate the effect of diltiazem ointment after surgery.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Iran, Islamic Republic of | |
Sina General Hospital | |
Tehran, Iran, Islamic Republic of |
Principal Investigator: | Farshad Jalili, Resident | Sina Hospital |
Responsible Party: | ( Bagher Larijani ) |
Study ID Numbers: | 724 |
Study First Received: | April 19, 2009 |
Last Updated: | May 2, 2009 |
ClinicalTrials.gov Identifier: | NCT00893100 History of Changes |
Health Authority: | United States: Food and Drug Administration; Iran: Ministry of Health |
Calcium, Dietary Vasodilator Agents Verapamil Diltiazem Calcium Channel Blockers |
Pain Anti-Arrhythmia Agents Cardiovascular Agents Antihypertensive Agents |
Membrane Transport Modulators Vasodilator Agents Verapamil Molecular Mechanisms of Pharmacological Action Therapeutic Uses Diltiazem |
Calcium Channel Blockers Anti-Arrhythmia Agents Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |